Waksal Harlan

Director at Freenome, Inc. · on record since Jun 11, 2024
Director at Eloxx Pharmaceuticals, Inc. · on record since Nov 3, 2008
Former Director at Freenome, Inc. · on record since Jul 29, 2026
Director at Kadmon Holdings, Inc. · on record since Jul 26, 2016
President, CEO at Kadmon Holdings, Inc. · on record since Jul 26, 2016
Director at Lyra Therapeutics, Inc. · on record since Feb 18, 2022
Executive Chair at Lyra Therapeutics, Inc. · on record since Feb 18, 2022

Insider trading activity of Waksal Harlan

Transactions on record: 80; since Feb 24, 2009

Open-market buys: 13; $1.5M

Open-market sells: 0

Companies traded: 4; last filing Jul 29, 2026

Figures computed from official regulatory filings — .

Companies where Waksal Harlan has traded

Freenome, Inc.2 tx · Jul 29, 2026
Lyra Therapeutics, Inc.7 tx · $1.1M · Dec 11, 2024
Kadmon Holdings, Inc.25 tx · $29.4M · Nov 9, 2021
Eloxx Pharmaceuticals, Inc.46 tx · $1.3M · Nov 23, 2015

Track record of Waksal Harlan

Statistical track record

Free

Open-market buys: 21

Last buy: Nov 10, 2023

Win rates and median returns are available with a free account (5 insiders/month).

Transaction history of Waksal Harlan

Co-insiders of Waksal Harlan

This page republishes public regulatory disclosures.

Company	Filed	Type	Qty	Price	Value · USD	Src
Freenome, Inc.Security delisted	Jul 29, 2026	Other	30,000	—	—	SEC
Freenome, Inc.Security delisted	Jul 29, 2026	OtherD (derivative)	-30,000	—	—	SEC
Lyra Therapeutics, Inc.Listing on record	Dec 11, 2024	AwardD (derivative)	-128,333	0.00 USD	—	SEC
Lyra Therapeutics, Inc.Listing on record	Mar 20, 2024	Award	275,000	0.00 USD	—	SEC
Lyra Therapeutics, Inc.Listing on record	Nov 13, 2023	Buy	25,000	2.96 USD	$74K	SEC
Lyra Therapeutics, Inc.Listing on record	Feb 2, 2023	AwardD (derivative)	200,000	0.00 USD	—	SEC
Lyra Therapeutics, Inc.Listing on record	Jun 21, 2022	AwardD (derivative)	953,002	0.00 USD	—	SEC
Lyra Therapeutics, Inc.Listing on record	Apr 13, 2022	Buy	236,966	4.22 USD	$1M	SEC
Lyra Therapeutics, Inc.Listing on record	Feb 18, 2022	AwardD (derivative)	520,000	0.00 USD	—	SEC
Kadmon Holdings, Inc.Listing unverified	Nov 9, 2021	OtherD (derivative)	2,000,000	5.54 USD	$11.1M	SEC
Kadmon Holdings, Inc.Listing unverified	Nov 9, 2021	OtherD (derivative)	655,000	5.86 USD	$3.8M	SEC
Kadmon Holdings, Inc.Listing unverified	Nov 9, 2021	OtherD (derivative)	982,500	5.44 USD	$5.3M	SEC
Kadmon Holdings, Inc.Listing unverified	Nov 9, 2021	OtherD (derivative)	750	3.50 USD	$2.6K	SEC
Kadmon Holdings, Inc.Listing unverified	Nov 9, 2021	OtherD (derivative)	1,350,000	5.35 USD	$7.2M	SEC
Kadmon Holdings, Inc.Listing unverified	Nov 9, 2021	Other	-177,945	9.50 USD	$1.7M	SEC
Kadmon Holdings, Inc.Listing unverified	May 17, 2021	Award	25,000	3.56 USD	$89K	SEC
Kadmon Holdings, Inc.Listing unverified	Apr 6, 2021	AwardD (derivative)	327,498	—	—	SEC
Kadmon Holdings, Inc.Listing unverified	Jan 12, 2021	AwardD (derivative)	2,000,000	0.00 USD	—	SEC
Kadmon Holdings, Inc.Listing unverified	Sep 10, 2020	AwardD (derivative)	109,167	—	—	SEC
Kadmon Holdings, Inc.Listing unverified	Mar 16, 2020	Buy	16,000	2.93 USD	$46.9K	SEC
Kadmon Holdings, Inc.Listing unverified	Mar 11, 2020	Award	5,882	2.84 USD	$16.7K	SEC
Kadmon Holdings, Inc.Listing unverified	Mar 11, 2020	Award	7,716	2.25 USD	$17.4K	SEC
Kadmon Holdings, Inc.Listing unverified	Mar 11, 2020	Buy	12,600	3.96 USD	$49.9K	SEC
Kadmon Holdings, Inc.Listing unverified	Nov 19, 2019	AwardD (derivative)	1,350,000	0.00 USD	—	SEC
Kadmon Holdings, Inc.Listing unverified	Nov 19, 2019	AwardD (derivative)	1,350,000	0.00 USD	—	SEC

Company	Filed	Type	Qty	Price	Value · USD	Src
Freenome, Inc.Security delisted	Jul 29, 2026	Other	30,000	—	—	SEC
Freenome, Inc.Security delisted	Jul 29, 2026	OtherD (derivative)	-30,000	—	—	SEC
Lyra Therapeutics, Inc.Listing on record	Dec 11, 2024	AwardD (derivative)	-128,333	0.00 USD	—	SEC
Lyra Therapeutics, Inc.Listing on record	Mar 20, 2024	Award	275,000	0.00 USD	—	SEC
Lyra Therapeutics, Inc.Listing on record	Nov 13, 2023	Buy	25,000	2.96 USD	$74K	SEC
Lyra Therapeutics, Inc.Listing on record	Feb 2, 2023	AwardD (derivative)	200,000	0.00 USD	—	SEC
Lyra Therapeutics, Inc.Listing on record	Jun 21, 2022	AwardD (derivative)	953,002	0.00 USD	—	SEC
Lyra Therapeutics, Inc.Listing on record	Apr 13, 2022	Buy	236,966	4.22 USD	$1M	SEC
Lyra Therapeutics, Inc.Listing on record	Feb 18, 2022	AwardD (derivative)	520,000	0.00 USD	—	SEC
Kadmon Holdings, Inc.Listing unverified	Nov 9, 2021	OtherD (derivative)	2,000,000	5.54 USD	$11.1M	SEC
Kadmon Holdings, Inc.Listing unverified	Nov 9, 2021	OtherD (derivative)	655,000	5.86 USD	$3.8M	SEC
Kadmon Holdings, Inc.Listing unverified	Nov 9, 2021	OtherD (derivative)	982,500	5.44 USD	$5.3M	SEC
Kadmon Holdings, Inc.Listing unverified	Nov 9, 2021	OtherD (derivative)	750	3.50 USD	$2.6K	SEC
Kadmon Holdings, Inc.Listing unverified	Nov 9, 2021	OtherD (derivative)	1,350,000	5.35 USD	$7.2M	SEC
Kadmon Holdings, Inc.Listing unverified	Nov 9, 2021	Other	-177,945	9.50 USD	$1.7M	SEC
Kadmon Holdings, Inc.Listing unverified	May 17, 2021	Award	25,000	3.56 USD	$89K	SEC
Kadmon Holdings, Inc.Listing unverified	Apr 6, 2021	AwardD (derivative)	327,498	—	—	SEC
Kadmon Holdings, Inc.Listing unverified	Jan 12, 2021	AwardD (derivative)	2,000,000	0.00 USD	—	SEC
Kadmon Holdings, Inc.Listing unverified	Sep 10, 2020	AwardD (derivative)	109,167	—	—	SEC
Kadmon Holdings, Inc.Listing unverified	Mar 16, 2020	Buy	16,000	2.93 USD	$46.9K	SEC
Kadmon Holdings, Inc.Listing unverified	Mar 11, 2020	Award	5,882	2.84 USD	$16.7K	SEC
Kadmon Holdings, Inc.Listing unverified	Mar 11, 2020	Award	7,716	2.25 USD	$17.4K	SEC
Kadmon Holdings, Inc.Listing unverified	Mar 11, 2020	Buy	12,600	3.96 USD	$49.9K	SEC
Kadmon Holdings, Inc.Listing unverified	Nov 19, 2019	AwardD (derivative)	1,350,000	0.00 USD	—	SEC
Kadmon Holdings, Inc.Listing unverified	Nov 19, 2019	AwardD (derivative)	1,350,000	0.00 USD	—	SEC